recro pharma inc (RAH:Stuttgart)
Transactions by RECRO PHARMA INC (RAH) in the last 6 months
Recro Pharma, Inc. (NasdaqCM:REPH) announced that it has entered into a definitive purchase agreement for private placement of 1,379,311 shares at $11.60 per share for gross proceeds of $16,000,008 on July 1, 2015. The transaction will involve participation three investors including institutional investors. The transaction is expected to close on or about July 7, 2015 and is subject to the satisfaction of customary closing condition. The securities will be issued pursuant ...
Recro Pharma, Inc. (NasdaqCM:REPH) agreed to acquire Alkermes Gainesville LLC and Daravita Limited from Alkermes Pharma Ireland Limited and Eagle Holdings USA, Inc. for approximately $170 million on March 7, 2015. Recro Pharma will acquire Alkermes Gainesville LLC from Eagle Holdings USA, Inc. and Daravita Limited from Alkermes Pharma Ireland Limited. The consideration will be satisfied by $50 million in cash and receipt by Alkermes Pharma Ireland of up to $120 million ...
Eagle Holdings USA, Inc.
|No competitor information is available for RAH.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|